News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hegde Priti
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/05/2023 |
4
| Hegde Priti (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 226,464 options to buy
@ $0
Granted 109,746 options to buy
@ $0
Granted 152,376 options to buy
@ $0 |
|
| 07/03/2023 |
4
| Hegde Priti (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 500,000 options to buy
@ $0 |
|
| 06/01/2023 |
3
| Hegde Priti (Director) has filed a Form 3 on Adaptimmune Therapeutics PLC |
| 06/01/2023 |
4
| Hegde Priti (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Disposed/sold 16,800 options to buy
@ $0.97, valued at
$16.3k
Disposed/sold 12,100 options to buy
@ $5.21, valued at
$63k
Disposed/sold 24,968 options to buy
@ $16.02, valued at
$400k
|
|
| 12/19/2022 |
4
| Hegde Priti (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 16,800 options to buy
@ $0.97, valued at
$16.3k
|
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|